Literature DB >> 29656351

Treatment of Colorectal Cancer: a Multidisciplinary Approach.

G Anania1, G Resta1, S Marino1, N Fabbri2, L Scagliarini1, I Marchitelli3, F Fiorica4, G Cavallesco1.   

Abstract

BACKGROUND: Colorectal cancer is the third most prevalent cancer in the world, preceded by prostate and lung cancers in men (10%) and breast and lung cancers in women (9.4%). Colorectal cancer is the fourth leading cause of death in men (7.6%) and the third in women (8.6%). A multidisciplinary approach has radically changed the way we deal with this disease among all specialist fields.
PURPOSE: In this study, we propose comparing the multidisciplinary experience group (started in 2012) of S. Anna Hospital (University of Ferrara) with the previous approach to rectal cancer before the advent of the multidisciplinary program.
RESULTS: We find that more study depth of neoplastic disease as well as of each individual patient leads to more accurate staging and to a weighted therapy based on the needs of the individual. All the studies were performed in accordance with the guidelines established by the European and Italian associations.

Entities:  

Keywords:  Colorectal cancer; Laparoscopic surgery; Multidisciplinary group

Year:  2019        PMID: 29656351     DOI: 10.1007/s12029-018-0100-9

Source DB:  PubMed          Journal:  J Gastrointest Cancer


  4 in total

1.  Upregulated LINC01088 facilitates malignant phenotypes and immune escape of colorectal cancer by regulating microRNAs/G3BP1/PD-L1 axis.

Authors:  Chenmeng Li; Bei Pan; Xuhong Wang; Xiangxiang Liu; Jian Qin; Tianyi Gao; Huiling Sun; Yuqin Pan; Shukui Wang
Journal:  J Cancer Res Clin Oncol       Date:  2022-03-31       Impact factor: 4.322

2.  Obesity-Associated Differentially Methylated Regions in Colon Cancer.

Authors:  John J Milner; Zhao-Feng Chen; James Grayson; Shyang-Yun Pamela Koong Shiao
Journal:  J Pers Med       Date:  2022-04-20

3.  Preliminary evaluation of a new initiative to centralize colorectal cancer care during the COVID-19 epidemic in Shanghai, China: a retrospective study.

Authors:  Rui Liu; Xuejing Yu; Xueyun Zeng; Zheng Wang; Danqing Zhou; Zhongchen Liu; Feng Liu; Chengle Zhuang; Ying Zhuang; Ji Zhang; Peiqin Niu; Ben Yan; Rui Zhi; Jiyu Li; Jiaoling Huang; Huanlong Qin
Journal:  Ann Transl Med       Date:  2022-01

4.  Retracted Article: Daphnetin inhibits proliferation and glycolysis in colorectal cancer cells by regulating the PI3K/Akt signaling pathway.

Authors:  Zhikuan He; Wenxing Dong; Kunhou Yao; Changjiang Qin; Baomin Duan
Journal:  RSC Adv       Date:  2018-10-08       Impact factor: 4.036

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.